Search

Search articles for

Advanced filters

Published After

Published Before

By Author

Search Results

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, Compared With Placebo and Apremilast in Moderate to Severe Psoriasis: Integrated Laboratory Parameter Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials

Diamant Thaci, Kenneth Gordon , Melinda Gooderham, Bruce Strober , Neil Korman, Subhashis Banerjee, Subhashis Banerjee, Elizabeth Colston, Jonghyeon Kim, John Throup, Akimichi Morita

Page s37

Poster PDF

1 - 1 of 1 items

Make a Submission

SKIN is a bi-monthly, peer-reviewed, online medical journal dedicated to providing an enhanced route to disseminate new dermatologic knowledge on all aspects of cutaneous disease. The Journal is Open Access. ISSN: 2574-1624

Important Links

About the Journal
Editorial Team
Submissions
Contact

Contact

Email: [email protected]
Website: www.jofskin.org
Mailing Address: PO Box 569 Millwood NY 10546

OJS Hosting, Support, and Customization by: OpenJournalSystems.com